Cargando…
Overcoming Physiological Barriers to Nanoparticle Delivery—Are We There Yet?
The exploitation of nanosized materials for the delivery of therapeutic agents is already a clinical reality and still holds unrealized potential for the treatment of a variety of diseases. This review discusses physiological barriers a nanocarrier must overcome in order to reach its target, with an...
Autores principales: | Thomas, Oliver S., Weber, Wilfried |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928054/ https://www.ncbi.nlm.nih.gov/pubmed/31921819 http://dx.doi.org/10.3389/fbioe.2019.00415 |
Ejemplares similares
-
Overcoming technological barriers in microfluidics: Leakage testing
por: Silverio, Vania, et al.
Publicado: (2022) -
Overcoming Energetic Barriers in Acetogenic C1 Conversion
por: Katsyv, Alexander, et al.
Publicado: (2020) -
Unlocking cellular barriers: silica nanoparticles and fullerenol conjugated cell-penetrating agents for enhanced intracellular drug delivery
por: Ravelo-Nieto, Eduardo, et al.
Publicado: (2023) -
MoCloFlex: A Modular Yet Flexible Cloning System
por: Klein, Carlo A., et al.
Publicado: (2019) -
A Challenge for Engineering Biomimetic Microvascular Models: How do we Incorporate the Physiology?
por: Lampejo, Arinola O., et al.
Publicado: (2022)